Evidence map›Paper›PMID 32398966›Full record

ArticleInternational journal of biological sciences2020

Cilostazol alleviate nicotine induced cardiomyocytes hypertrophy through modulation of autophagy by CTSB/ROS/p38MAPK/JNK feedback loop.

Shu-Ya Wang, Xi Ni, Ke-Qing Hu, Fan-Liang Meng, Min Li, Xiao-Li Ma, Ting-Ting Meng, Hui-Hui Wu, Di Ge, Jing Zhao and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Shu-Ya WangJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Xi NiJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Ke-Qing HuJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Fan-Liang MengAffiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Min LiJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Xiao-Li MaJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Ting-Ting MengJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Hui-Hui WuJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Di GeSchool of Biological Science and Technology, University of Jinan, China.
Jing ZhaoDevelopment Biology, School of Life Science, Shandong University, Jinan, China.
Ying LiJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Guo-Hai SuJinan Central Hospital Affiliated to Shandong University, Jinan, China.
Jinan Central Hospital · CNShandong University · CNAffiliated Hospital of Shandong University of Traditional Chinese Medicine · CNUniversity of Jinan · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotine is proved to be an important factor for cardiac hypertrophy. Autophagy is important cell recycling system involved in the regulation of cardiac hypertrophy. Cilostazol, which is often used in the management of peripheral vascular disease. However, the effects of cilostazol on nicotine induced autophagy and cardiac hypertrophy are unclear. Here, we aim to determine the role and molecular mechanism of cilostazol in alleviating nicotine-induced cardiomyocytes hypertrophy through modulating autophagy and the underlying mechanisms. Our results clarified that nicotine stimulation caused cardiomyocytes hypertrophy and autophagy flux impairment significantly in neonatal rat ventricular myocytes (NRVMs), which were evidenced by augments of LC3-II and p62 levels, and impaired autophagosomes clearance. Interestingly, cathepsin B (CTSB) activity decreased dramatically after stimulation with nicotine in NRVMs, which was crucial for substrate degradation in the late stage of autophagy process, and cilostazol could reverse this effect dramatically. Intracellular ROS levels were increased significantly after nicotine exposure. Meanwhile, p38MAPK and JNK were activated after nicotine treatment. By using ROS scavenger N-acetyl-cysteine (NAC) could reverse the effects of nicotine by down-regulation the phosphorylation of p38MAPK and JNK pathways, and pretreatment of specific inhibitors of p38MAPK and JNK could restore the autophagy impairment and cardiomyocytes hypertrophy induced by nicotine. Moreover, CTSB activity of lysosome regained after the treatment with cilostazol. Cilostazol also inhibited the ROS accumulation and the activation of p38MAPK and JNK, which providing novel connection between lysosome CTSB and ROS/p38MAPK/JNK related oxidative stress pathway. This is the first demonstration that cilostazol could alleviate nicotine induced cardiomyocytes hypertrophy through restoration of autophagy flux by activation of CTSB and inhibiting ROS/p38/JNK pathway, exhibiting a feedback loop on regulation of autophagy and cardiomyocytes hypertrophy.

Indexed as

AnimalsBronchodilator AgentsCathepsin BCilostazolGene Expression RegulationMAP Kinase Kinase 4Myocytes, CardiacNicotineNicotinic Agonistsp38 Mitogen-Activated Protein KinasesProto-Oncogene ProteinsRatsReceptor Protein-Tyrosine KinasesBronchodilator AgentsCathepsin BCilostazolCtsb protein, ratMAP Kinase Kinase 4NicotineNicotinic Agonistsp38 Mitogen-Activated Protein KinasesProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesRos1 protein, ratautophagycardiomyocytes hypertrophyCTSBnicotinep38MAPK/JNK.ROS

Identifiers

PMID32398966
PMCPMC7211170
OpenAlexW3022869253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.